Alina Franzen Selected Research

homeobox protein PITX3

1/2017

PITX3 DNA methylation is an independent predictor of overall survival in patients with head and neck squamous cell carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alina Franzen Research Topics

Disease

14	Neoplasms (Cancer) 01/2023 - 10/2012
12	Squamous Cell Carcinoma of Head and Neck 01/2023 - 10/2013
3	Squamous Cell Neoplasms (Squamous Cell Cancer) 01/2017 - 10/2013
3	Lung Neoplasms (Lung Cancer) 09/2014 - 10/2012
2	Infections 01/2022 - 10/2013
2	Papillomavirus Infections 01/2018 - 07/2014
2	Colorectal Neoplasms (Colorectal Cancer) 07/2017 - 01/2013
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 10/2013 - 10/2012
2	Lymphatic Metastasis 01/2013 - 10/2012
1	Melanoma (Melanoma, Malignant) 01/2024
1	Residual Neoplasm 01/2023
1	Carcinogenesis 01/2022
1	Uveal melanoma 01/2022
1	Papillary Thyroid Cancer 01/2020
1	Neoplasm Metastasis (Metastasis) 10/2013
1	Carcinoma (Carcinomatosis) 01/2013

Drug/Important Bio-Agent (IBA)

9	Biomarkers (Surrogate Marker)IBA 01/2024 - 10/2013
7	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2013
5	Messenger RNA (mRNA)IBA 01/2023 - 10/2015
5	Type 1 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 1)IBA 09/2014 - 10/2012
3	Cell-Free Nucleic AcidsIBA 01/2023 - 01/2017
3	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 11/2016
3	Long Noncoding RNAIBA 01/2020 - 11/2016
3	ParaffinIBA 11/2016 - 10/2012
3	Formaldehyde (Formol)FDA Link 11/2016 - 10/2012
2	SeptinsIBA 01/2023 - 07/2017
2	N-acetyltalosaminuronic acid (NAT)IBA 01/2018 - 01/2017
2	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 10/2013 - 10/2012
1	Decitabine FDA Link 01/2023
1	Immune Checkpoint InhibitorsIBA 01/2023
1	CTLA-4 AntigenIBA 01/2023
1	MethyltransferasesIBA 01/2023
1	InterferonsIBA 01/2022
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2018
1	homeobox protein PITX3IBA 01/2017
1	hydrogen sulfite (bisulfite)IBA 11/2016
1	Type 3 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 3)IBA 10/2016
1	infigratinibIBA 10/2015
1	Tyrosine Kinase InhibitorsIBA 10/2015
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 09/2014
1	Cisplatin (Platino)FDA LinkGeneric 07/2014
1	Nicotine FDA Link 10/2013
1	Indicators and Reagents (Reagents)IBA 01/2013

Therapy/Procedure

5	Therapeutics 07/2014 - 10/2012
4	Immunotherapy 01/2024 - 01/2022
1	Chemoradiotherapy 11/2016
1	Adjuvant Chemoradiotherapy 11/2016
1	Combined Modality Therapy 09/2014